Sign in to view content

Interview Reversal of Retinal Ischemia After Anti-VEGF Therapy

Thomas R. Friberg, MD

Video
Published 2019

Related

Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021
Are There Safety Concerns With Bevacizumab for ROP
Robert L. Avery, MD
Updates from the Field
2017
Treatment of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy With Intravitreal Aflibercept Injection: 52-Week Results From PANORAMA
W. Lloyd Clark, MD, FASRS
Annual Meeting Talks
2019

Category: Retinal Vascular Disease

See more